United States Pharmacopeia 800: Hazardous Pharmaceuticals Part 8 Flashcards
1
Q
What chapter in the USP is HD listed in?
A
Chapter 800
2
Q
Exposure to HD can occur during ___, ___, or ____
A
receipt, packaging, or disposal
3
Q
When receiving inventory, there may be HD residue on ____
A
packaging
4
Q
During the process of compounding, handling of powders or solutions can allow for skin or inhalation ____
A
contact
5
Q
The PEC laminar airflow workbench (LAFW) should not be used for HD ____
A
compounding
6
Q
The acceptable C-PECs for compounding of HDs are:
A
Class II biologic safety cabinet—BSC
or
Compounding aseptic containment isolator—CACI
